近日，远大医药（0512.HK）在创新药物领域频传捷报，其旗下的钇 90（SIR - Spheres® 钇 （90Y） 微球注射液）、OC - 01（酒石酸伐尼克兰鼻喷雾剂）以及 STC3141三款创新产品，在各自治疗领域取得了重大进展，为众多患者带来了新的希望。钇 90 微球注射液在肿瘤治疗领域大放异彩。该产品采用全球领先的介入技术，将钇（90Y）树脂微球注入肝脏肿瘤血管，释放高能量 β 放射线...
Source Link近日，远大医药（0512.HK）在创新药物领域频传捷报，其旗下的钇 90（SIR - Spheres® 钇 （90Y） 微球注射液）、OC - 01（酒石酸伐尼克兰鼻喷雾剂）以及 STC3141三款创新产品，在各自治疗领域取得了重大进展，为众多患者带来了新的希望。钇 90 微球注射液在肿瘤治疗领域大放异彩。该产品采用全球领先的介入技术，将钇（90Y）树脂微球注入肝脏肿瘤血管，释放高能量 β 放射线...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.